Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Approaches for Developing Novel Microtubule Targeting Agents (MTAs) for Therapeutic Exploitation

Author(s): Aswini Krishnan, James Wilson and Hing Y. Leung

Volume 18 , Issue 19 , 2012

Page: [2804 - 2810] Pages: 7

DOI: 10.2174/138161212800626111

Price: $65

Abstract

The microtubule (MT) represents a highly validated target for therapy. Insights into the complex nature of the dynamic microtubule physiology will provide the basis for developing novel microtubule targeting agents with enhanced efficacy and minimised toxicity. In this article, with an emphasis on translational applications, we have summarised relevant aspects of tubulin physiology in the context of developing MT binding agents as therapeutic agents. Case studies were included to illustrate therapeutic developments in prostate cancer and current strategies to discover novel agents or targets for therapy.

Keywords: Microtubule (MT), microtubule associated proteins (MAPs), microtubule targeting agents (MTAs), chemotherapy, tubulin heterodimers, polymerases, angiogenesis, neutropenia, p21-activated kinase 6 (PAK6), prostate cancer


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy